Disease/Infection News

RSS

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

NanoBio Corporation today announced that the company will present data at The Keystone Symposia Conference, The Modes of Action of Vaccine Adjuvants, in Seattle on October 12, 2014.

9 Oct 2014

KNCV becomes prime partner for USAID's flagship tuberculosis program

KNCV Tuberculosis Foundation, the Dutch NGO specialized in the fight against tuberculosis, will be the prime partner for the United States Agency for International Development in their new five year flagship program 'Challenge TB'.

9 Oct 2014

Researchers are developing compounds to combat causative agents of periodontitis

A total 12 million Germans suffer from periodontitis. If the inflammation remains untreated, this could lead to tooth loss. However, it is also suspected of triggering many other diseases, like cardiopulmonary diseases. Researchers are studying the interactions, and developing compounds to combat the causative agents.

9 Oct 2014

EPFL scientists discover two molecules that could overcome multidrug resistance in tuberculosis

Using a high-throughput screening assay, EPFL scientists have discovered two small molecules that could overcome the multidrug resistance of the bacterium that causes tuberculosis.

9 Oct 2014

Kansas State professor aims to develop vaccines to protect against tick-borne diseases

A Kansas State University professor is researching ways to keep animals and humans safe from tick-borne diseases.

9 Oct 2014

Molecular biologists awarded NIH grant to identify new compounds to fight malaria parasite

A team of molecular biologists, jointly led by Clemson University professor Jim Morris, was awarded a $151,121 grant from the National Institutes of Health to identify new compounds with anti-malarial activity for a deadly parasite species that kills hundreds of thousands of people each year.

9 Oct 2014

Journal of Disaster Medicine and Public Health Preparedness launches special issue on Ebola

The Society for Disaster Medicine and Public Health is committed to examining the details of individual disasters and public health crises. With the recent arrival of Ebola in the United States, the journal is launching a special issue on the virus. The journal will serve as an educated and authoritative voice on the virus, risk and threat level, potential of outbreak, preparation and response for the public and media.

9 Oct 2014

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

The federal government has awarded a patent to the Translational Genomics Research Institute and Northern Arizona University for a test that can detect — and assist in the treatment of — the H1N1 pandemic flu strain.

9 Oct 2014

Columbia Nursing researcher suggests ways to prevent nursing home infections

Nursing home infection rates are on the rise, a study from Columbia University School of Nursing found, suggesting that more must be done to protect residents of these facilities from preventable complications. The study, which examined infections in U.S. nursing homes over a five-year period, found increased infection rates for pneumonia, urinary tract infections (UTIs), viral hepatitis, septicemia, wound infections, and multiple drug-resistant organisms (MDROs).

8 Oct 2014

U-M researchers propose new ways to fight sepsis

A decade ago, America's health care community took on heart attacks with gusto, harnessing the power of research and data to make sure that every patient got the best possible care.

8 Oct 2014

Contaminated duodenoscopes associated with E coli outbreak at Illinois hospital

Despite no lapses in the disinfection process recommended by the manufacturer being identified, specialized gastrointestinal endoscopes called duodenoscopes had bacterial contamination associated with an outbreak of a highly resistant strain of E coli at a hospital in Illinois, according to a study in the October 8 JAMA, a theme issue on infectious disease.

8 Oct 2014

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Astellas reported today that isavuconazole demonstrated successful outcomes in the treatment of mucormycosis according to data from the phase 3 isavuconazole VITAL study being presented at IDWeek on October 10, 2014, in Philadelphia, Pa.

8 Oct 2014

Researchers use computer based predictions to combat AIDS

The battle against AIDS cannot be won in the laboratory alone. To fight the potentially deadly virus that 34 million people are suffering from we need help from computers.

8 Oct 2014

Study: H7N9 flu vaccine combined with adjuvant is essential to promote protective immune response

A large, NIH-sponsored clinical trial of an experimental H7N9 avian influenza vaccine found an immune response that was believed to be protective in 59 percent of study participants who received two injections of the inactivated vaccine at the lowest dosage tested when mixed with an adjuvant – a component that boosts the body's immune response and enhances the effectiveness of inactivated influenza vaccines.

8 Oct 2014

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Nabriva Therapeutics AG, a biotechnology company focused on developing pleuromutilins, a new class of antibiotics for the treatment of serious infections caused by resistant Gram-positive and Gram-negative pathogens, announced today that the United States Food and Drug Administration has granted Qualified Infectious Disease Product (QIDP) as well as Fast Track status designation to Nabriva's lead product lefamulin, for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI).

8 Oct 2014

Montefiore Medical Center experts raise awareness about the importance of flu vaccines

Each year, 30,000 people die from influenza infection and its complications. In an effort to get ahead of the upcoming flu season, experts at Montefiore Medical Center are raising awareness about the importance of the flu vaccine, which remains the best option to reduce a person's risk of contracting the virus. The flu season can start as early as late September and usually runs for about 12 to 15 weeks.

8 Oct 2014

Universal MRSA screening may be too costly for individual hospital to adopt

Numerous experts and policy makers have called for hospitals to screen patients for methicillin-resistant Staphylococcus aureus (MRSA) infections and isolate anyone testing positive to prevent the spread of these so-called "Superbugs" in healthcare settings.

8 Oct 2014

LLNL scientists issued patent for producing antimicrobial compounds to fight superbugs

Superbugs, antibiotic-resistant bacteria, have been on the rise since antibiotics were first introduced 80 years ago. That's because these germ-fighting agents have lost their punch from being overprescribed and misused, allowing bacteria pathogens to develop immunities against them.

8 Oct 2014

Study finds that hospitalized patients wash their hands infrequently

Hospital visitors and staff are greeted with hand sanitizer dispensers in the lobby, by the elevators and outside rooms as reminders to wash their hands to stop infections, but just how clean are patients' hands?

8 Oct 2014

Sleeping with dentures increases pneumonia risk in elderly

Poor oral health and hygiene are increasingly recognized as major risk factors for pneumonia among the elderly. To identify modifiable oral health-related risk factors, lead researcher Toshimitsu Iinuma, Nihon University School of Dentistry, Japan, and a team of researchers prospectively investigated associations between a constellation of oral health behaviors and incidences of pneumonia in the community-living of elders 85 years of age or older.

8 Oct 2014

Disease/Infection News

NanoBio to highlight prophylactic NE HSV-2 vaccine candidate at The Keystone Symposia Conference

KNCV becomes prime partner for USAID's flagship tuberculosis program

Researchers are developing compounds to combat causative agents of periodontitis

EPFL scientists discover two molecules that could overcome multidrug resistance in tuberculosis

Kansas State professor aims to develop vaccines to protect against tick-borne diseases

Molecular biologists awarded NIH grant to identify new compounds to fight malaria parasite

Journal of Disaster Medicine and Public Health Preparedness launches special issue on Ebola

TGen, NAU awarded patent for genomics-based test to detect H1N1 pandemic flu strain

Columbia Nursing researcher suggests ways to prevent nursing home infections

U-M researchers propose new ways to fight sepsis

Contaminated duodenoscopes associated with E coli outbreak at Illinois hospital

Isavuconazole demonstrates successful outcomes in treatment of mucormycosis

Researchers use computer based predictions to combat AIDS

Study: H7N9 flu vaccine combined with adjuvant is essential to promote protective immune response

FDA grants QIDP and Fast Track designation to Nabriva's lefamulin for treatment of CABP, ABSSSI

Montefiore Medical Center experts raise awareness about the importance of flu vaccines

Universal MRSA screening may be too costly for individual hospital to adopt

LLNL scientists issued patent for producing antimicrobial compounds to fight superbugs

Study finds that hospitalized patients wash their hands infrequently

Sleeping with dentures increases pneumonia risk in elderly

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News